Close



Mar 20, 2024 08:00AM
Mar 14, 2024 04:01PM
Mar 6, 2024 08:01AM
Mar 6, 2024 08:00AM
Feb 5, 2024 08:00AM
Jan 19, 2024 08:30AM
Jan 19, 2024 08:30AM Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Jan 16, 2024 09:25AM
Jan 16, 2024 09:25AM
Jan 16, 2024 09:23AM
Jan 16, 2024 09:22AM
Dec 21, 2023 08:00AM
Nov 2, 2023 04:01PM
Nov 2, 2023 08:00AM Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers
Sep 6, 2023 04:08PM
Sep 6, 2023 04:05PM
Aug 3, 2023 04:01PM
Jul 6, 2023 08:00AM
Jun 26, 2023 04:45PM
Jun 21, 2023 04:30PM
Jun 7, 2023 09:17AM Vaxart (VXRT) Prices 16M Share Offering
Jun 7, 2023 09:16AM
Jun 6, 2023 04:02PM
Jun 6, 2023 04:01PM
Jun 6, 2023 08:00AM
May 4, 2023 04:01PM
Mar 15, 2023 04:01PM
Feb 14, 2023 08:00AM Vaxart Doses First Subject in the Phase 2 Clinical Trial of its Bivalent Norovirus Candidate
Dec 1, 2022 08:00AM
Nov 8, 2022 04:01PM
Sep 7, 2022 08:30AM
Aug 31, 2022 04:30PM
Aug 8, 2022 04:01PM
Aug 8, 2022 08:03AM
Aug 8, 2022 08:00AM Vaxart Appoints W. Mark Watson to its Board of Directors
Aug 5, 2022 08:00AM
Jul 28, 2022 04:05PM
Jul 27, 2022 08:00AM
Jul 27, 2022 08:00AM
Jul 20, 2022 08:32AM
Jul 20, 2022 08:30AM
Jul 1, 2022 09:00AM Vaxart Provides an Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022 to Vote by July 5, 2022, at 11:59 p.m. ET
Jun 30, 2022 08:00AM
Jun 16, 2022 04:05PM
Jun 8, 2022 09:05AM
Jun 3, 2022 08:05AM
Jun 3, 2022 08:00AM
Jun 2, 2022 08:30AM
Jun 2, 2022 08:30AM Vaxart Reports Positive Preliminary Data from the Phase 1b Trial of its Oral Norovirus Vaccine Candidates in Elderly Adults
Jun 2, 2022 08:00AM

251,614 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All